TrialVaccine2022

A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults.

Katherine V Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.